ArticleCase reports in urology2026
Adult Granulosa Cell Tumor With Low-Level Amplifications of
Article in Case reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adult Granulosa Cell Tumor With Low-Level Amplifications ofCase reports in urology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Testicular adult granulosa cell tumors (AGCTs) are exceptionally rare neoplasms that are thought to be the male counterpart of ovarian granulosa cell tumors (GCT). Here, we present a 50-year-old African American male who initially presented with right testicular pain and swelling, with ultrasound revealing a 2.0-cm heterogeneous hypoechoic lesion along the upper pole/interpolar right testicle with internal vascularity. Microscopic examination was consistent with AGCT, demonstrating monomorphic cells with elongated nuclei containing numerous small grooves, resembling ovarian granulosa cells, and scant cytoplasm arranged in trabeculae and sheets. Immunohistochemical stains of the tumor were positive for inhibin, vimentin, and weakly positive for calretinin, S100, and Ki67 (10%). Next Generation Sequencing (NGS) showed low-level amplifications of
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.